Filter sub products categories alphabetically

No sub product categories were found.

Favipiravir is an antiviral drug used in the treatment of mild to moderate cases of COVID-19. It functions by inhibiting the replication of the SARS-CoV-2 virus, which helps lower the viral load, curbs the progression of the disease, and promotes quicker recovery. It received approval from the USFDA on October 22, 2020.

BRAND NAME:

Favivir – It is available as film coated tablet contains Favipiravir 200mg as the main active ingredient.

MECHANISM OF ACTION:

Favipiravir is metabolized into ribosyl triphosphate, which is then converted into its active form, Favipiravir-RTP. This active form inhibits the enzyme essential for viral replication, thereby preventing the virus responsible for the infection from multiplying in the body.

PHARMACOKINETICS:

Absorption: The bioavailability of favipiravir is almost complete at 97.6%. The mean Cmax for the recommended dosing schedule of favipiravir is 51.5µg/ml.

Distribution: Favipiravir has an apparent volume of distribution ranging from 15 to 20 liters and exhibits approximately 54% binding to plasma proteins. 

Metabolism: Favipiravir is metabolized in the liver by aldehyde oxidase and xanthine oxidase converts to its inactive hydroxylated metabolite.

Excretion: Favipiravir takes 2 -5 hours for elimination. It is mainly excreted through urine as inactive metabolites and renal excretion of unchanged drug is minimal.

PHARMACODYNAMICS:

Favipiravir functions as a prodrug and undergoes ribosylation and phosphorylation intracellularly to become the active favipiravir-RTP. Fvaipiravir –RTP binds to and inhibits RNA-dependent RNA polymerase, which ultimately prevents viral transcription and replication.

DOSAGE ANDADMINISTRATION:

Favipiravir is available in the form of oral suspension and tablets. Depending on the patient's condition and the severity of the infection the dose will be recommended. 

For Covid-19, the recommended dose is,

  • Day 1: 1600mg or 1800mg twice daily.
  • Day 2 – 10: 600mg or 800mg twice daily.
  • Duration: 7 -14 days depending on severity and clinical response.

For influenza, the recommended dose is

  • Day 1: 1600mg twice daily
  • Day 2 – 5: 600mg twice daily
  • Duration: 5 days.

DRUG INTERACTIONS:

Some medicines should be avoided while taking favipiravir as these drugs can interact and cause severe adverse effects. Below are the few drugs that should be avoided while taking favipiravir.

  • Anti-TB: Pyrazinamide
  • Hyperglycaemic agent: Repaglinide
  • Methylxanthines: Theophylline
  • Anti-viral: Famciclovir, Acyclovir
  • NSAID: Sulindac

CONTRAINDICATIONS:

Contraindicated in patients with known allergy to favipiravir or any of its components.

ADVERSE EFFECTS:

  • Diarrhea
  • Hyperuricemia
  • Reduced neutrophil count
  • Nausea
  • Vomiting
  • Abdominal pain

TOXICITY:

Taking overdose can cause toxic effects that lead to

  • Seizures
  • Death